Sterigenics, a Subsidiary of Sotera Health Co., Reaches $34 Million Settlement in Willowbrook EO Claims

Reuters
07-24
Sterigenics, a Subsidiary of Sotera Health Co., Reaches $34 Million Settlement in Willowbrook EO Claims

Sterigenics U.S., LLC, a subsidiary of Sotera Health Company, has reached a binding term sheet agreement to resolve 129 ethylene oxide claims related to its former facility in Willowbrook, Illinois. The settlement includes ten claims set for trials in the Circuit Court of Cook County in 2025 and 2026, as well as other claims from an additional 119 claimants. As part of the agreement, Sterigenics will pay $34 million, and the plaintiffs' claims will be dismissed with prejudice. The settlement process is anticipated to take 60 to 90 days and requires several conditions to be met, including full claimant participation and a good faith determination by the court. Sterigenics denies any liability, and the settlement is not to be interpreted as an admission of safety hazards from the facility's emissions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sotera Health Co. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001822479-25-000036), on July 24, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10